Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study
Identifieur interne : 001490 ( Main/Exploration ); précédent : 001489; suivant : 001491Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study
Auteurs : Tobias Lahmer [Allemagne] ; Andreas Knopf [Allemagne] ; Ines Lanzl [Allemagne] ; Uwe Heemann [Allemagne] ; Klaus Thuermel [Allemagne]Source :
- Rheumatology International [ 0172-8172 ] ; 2012-08-01.
English descriptors
Abstract
Abstract: We report the usage of the TNF-alpha antagonist Adalimumab in patients with progressive multisystem sarcoidosis. Three patients with multisystem sarcoidosis (MSS) were treated with Adalimumab for 12 months. All three patients were quickly responded to Adalimumab and experienced a nearly complete regression of the symptoms that lead to an intensive immunosuppression. However, some accompanying symptoms of sarcoidosis, such as splenomegalia, did not respond. One patient suffered 18 months later a new unspecified abdominal lymphadenopathy. TNF-alpha antagonists can be helpful agents in the treatment for MSS. However, the experience with TNF-alpha antagonists in patients with sarcoidosis is still limited. Multicenter trials and a comparison of the different agents are needed to validate the safety and efficacy in these patients. Optimal dosage, duration of therapy and long-term toxicity of anti-TNF therapy in patients with refractory sarcoidosis are yet to be determined in prospective trials.
Url:
DOI: 10.1007/s00296-011-1968-x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000352
- to stream Istex, to step Curation: 000352
- to stream Istex, to step Checkpoint: 000466
- to stream Main, to step Merge: 001492
- to stream Main, to step Curation: 001490
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study</title><author><name sortKey="Lahmer, Tobias" sort="Lahmer, Tobias" uniqKey="Lahmer T" first="Tobias" last="Lahmer">Tobias Lahmer</name></author><author><name sortKey="Knopf, Andreas" sort="Knopf, Andreas" uniqKey="Knopf A" first="Andreas" last="Knopf">Andreas Knopf</name></author><author><name sortKey="Lanzl, Ines" sort="Lanzl, Ines" uniqKey="Lanzl I" first="Ines" last="Lanzl">Ines Lanzl</name></author><author><name sortKey="Heemann, Uwe" sort="Heemann, Uwe" uniqKey="Heemann U" first="Uwe" last="Heemann">Uwe Heemann</name></author><author><name sortKey="Thuermel, Klaus" sort="Thuermel, Klaus" uniqKey="Thuermel K" first="Klaus" last="Thuermel">Klaus Thuermel</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CFAAC079BAC395E70CC5FC153B782B9DD6A00114</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s00296-011-1968-x</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-0WX1GSFQ-5/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000352</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000352</idno><idno type="wicri:Area/Istex/Curation">000352</idno><idno type="wicri:Area/Istex/Checkpoint">000466</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000466</idno><idno type="wicri:doubleKey">0172-8172:2011:Lahmer T:using:tnf:alpha</idno><idno type="wicri:Area/Main/Merge">001492</idno><idno type="wicri:Area/Main/Curation">001490</idno><idno type="wicri:Area/Main/Exploration">001490</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study</title><author><name sortKey="Lahmer, Tobias" sort="Lahmer, Tobias" uniqKey="Lahmer T" first="Tobias" last="Lahmer">Tobias Lahmer</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Nephrology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaninger Str. 22, 81675, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Allemagne</country></affiliation></author><author><name sortKey="Knopf, Andreas" sort="Knopf, Andreas" uniqKey="Knopf A" first="Andreas" last="Knopf">Andreas Knopf</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Ear, Nose and Throat Medicine, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Lanzl, Ines" sort="Lanzl, Ines" uniqKey="Lanzl I" first="Ines" last="Lanzl">Ines Lanzl</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Ophthalmology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Heemann, Uwe" sort="Heemann, Uwe" uniqKey="Heemann U" first="Uwe" last="Heemann">Uwe Heemann</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Nephrology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaninger Str. 22, 81675, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Thuermel, Klaus" sort="Thuermel, Klaus" uniqKey="Thuermel K" first="Klaus" last="Thuermel">Klaus Thuermel</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Nephrology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaninger Str. 22, 81675, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="ISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2012-08-01">2012-08-01</date><biblScope unit="volume">32</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="2367">2367</biblScope><biblScope unit="page" to="2370">2370</biblScope></imprint><idno type="ISSN">0172-8172</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0172-8172</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adalimumab</term><term>Neurosarcoidosis</term><term>Ocular sarcoidosis</term><term>Sarcoidosis</term><term>TNF-alpha antagonist</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: We report the usage of the TNF-alpha antagonist Adalimumab in patients with progressive multisystem sarcoidosis. Three patients with multisystem sarcoidosis (MSS) were treated with Adalimumab for 12 months. All three patients were quickly responded to Adalimumab and experienced a nearly complete regression of the symptoms that lead to an intensive immunosuppression. However, some accompanying symptoms of sarcoidosis, such as splenomegalia, did not respond. One patient suffered 18 months later a new unspecified abdominal lymphadenopathy. TNF-alpha antagonists can be helpful agents in the treatment for MSS. However, the experience with TNF-alpha antagonists in patients with sarcoidosis is still limited. Multicenter trials and a comparison of the different agents are needed to validate the safety and efficacy in these patients. Optimal dosage, duration of therapy and long-term toxicity of anti-TNF therapy in patients with refractory sarcoidosis are yet to be determined in prospective trials.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>Bavière</li><li>District de Haute-Bavière</li></region><settlement><li>Munich</li></settlement></list><tree><country name="Allemagne"><region name="Bavière"><name sortKey="Lahmer, Tobias" sort="Lahmer, Tobias" uniqKey="Lahmer T" first="Tobias" last="Lahmer">Tobias Lahmer</name></region><name sortKey="Heemann, Uwe" sort="Heemann, Uwe" uniqKey="Heemann U" first="Uwe" last="Heemann">Uwe Heemann</name><name sortKey="Knopf, Andreas" sort="Knopf, Andreas" uniqKey="Knopf A" first="Andreas" last="Knopf">Andreas Knopf</name><name sortKey="Lahmer, Tobias" sort="Lahmer, Tobias" uniqKey="Lahmer T" first="Tobias" last="Lahmer">Tobias Lahmer</name><name sortKey="Lanzl, Ines" sort="Lanzl, Ines" uniqKey="Lanzl I" first="Ines" last="Lanzl">Ines Lanzl</name><name sortKey="Thuermel, Klaus" sort="Thuermel, Klaus" uniqKey="Thuermel K" first="Klaus" last="Thuermel">Klaus Thuermel</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001490 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001490 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:CFAAC079BAC395E70CC5FC153B782B9DD6A00114
|texte= Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study
}}
| This area was generated with Dilib version V0.6.33. |  |